Aurinia Pharmaceuticals Inc.
AUPH
$15.99
$0.271.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 648.43% | 4,893.08% | 445.14% | 220.43% | 163.69% |
| Total Depreciation and Amortization | -0.23% | 0.02% | -0.44% | -2.14% | 23.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,220.18% | -1,280.31% | -46.52% | -28.03% | -53.41% |
| Change in Net Operating Assets | 137.90% | -261.22% | 200.17% | -8,325.77% | -181.32% |
| Cash from Operations | 159.65% | 205.62% | 320.15% | 5,488.60% | 415.30% |
| Capital Expenditure | 4.20% | 10.32% | -54.18% | 23.35% | 25.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -482.28% | -182.23% | 837.81% | 410.84% | 18.27% |
| Cash from Investing | -488.78% | -183.46% | 794.92% | 402.40% | 19.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.99% | -9.57% | 18.21% | 23.94% | 6.41% |
| Issuance of Common Stock | -51.12% | 61.23% | 43.20% | 19.52% | 17.86% |
| Repurchase of Common Stock | -21.77% | -132.72% | -387.12% | -356.65% | -320.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.48% | -116.15% | -302.45% | -282.60% | -282.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,391.01% | -109.32% | 489.49% | 140.57% | 108.02% |